267 related articles for article (PubMed ID: 24743592)
1. Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury.
Miyabe M; Ohashi K; Shibata R; Uemura Y; Ogura Y; Yuasa D; Kambara T; Kataoka Y; Yamamoto T; Matsuo K; Joki Y; Enomoto T; Hayakawa S; Hiramatsu-Ito M; Ito M; Van Den Hoff MJ; Walsh K; Murohara T; Ouchi N
Cardiovasc Res; 2014 Jul; 103(1):111-20. PubMed ID: 24743592
[TBL] [Abstract][Full Text] [Related]
2. Adipose-derived protein omentin prevents neointimal formation after arterial injury.
Uemura Y; Shibata R; Kanemura N; Ohashi K; Kambara T; Hiramatsu-Ito M; Enomoto T; Yuasa D; Joki Y; Matsuo K; Ito M; Hayakawa S; Ogawa H; Murohara T; Ouchi N
FASEB J; 2015 Jan; 29(1):141-51. PubMed ID: 25300621
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injury.
Kwon MY; Liu X; Lee SJ; Kang YH; Choi AM; Lee KU; Perrella MA; Chung SW
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2441-7. PubMed ID: 21903945
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of the prostaglandin E2 E-prostanoid 2 receptor exacerbates vascular neointimal formation in mice.
Zhu S; Xue R; Zhao P; Fan FL; Kong X; Zheng S; Han Q; Zhu Y; Wang N; Yang J; Guan Y
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1739-47. PubMed ID: 21636806
[TBL] [Abstract][Full Text] [Related]
5. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA PVT1/miR-590-5p/FSTL1 axis modulates the proliferation and migration of airway smooth muscle cells in asthma.
Wang WL; Luo XM; Zhang Q; Zhu HQ; Chen GQ; Zhou Q
Autoimmunity; 2021 May; 54(3):138-147. PubMed ID: 33825599
[TBL] [Abstract][Full Text] [Related]
7. C1q/TNF-related protein 1 prevents neointimal formation after arterial injury.
Kanemura N; Shibata R; Ohashi K; Ogawa H; Hiramatsu-Ito M; Enomoto T; Yuasa D; Ito M; Hayakawa S; Otaka N; Murohara T; Ouchi N
Atherosclerosis; 2017 Feb; 257():138-145. PubMed ID: 28131048
[TBL] [Abstract][Full Text] [Related]
8. Wild-type p53-induced phosphatase 1 promotes vascular smooth muscle cell proliferation and neointima hyperplasia after vascular injury via p-adenosine 5'-monophosphate-activated protein kinase/mammalian target of rapamycin complex 1 pathway.
Sun X; Li S; Gan X; Qiu C; Chen K; Pei H; Wang Q; Li D; Li X; Yang D; Yang Y
J Hypertens; 2019 Nov; 37(11):2256-2268. PubMed ID: 31136458
[TBL] [Abstract][Full Text] [Related]
9. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
[TBL] [Abstract][Full Text] [Related]
10. Sonic hedgehog-dependent activation of adventitial fibroblasts promotes neointima formation.
Dutzmann J; Koch A; Weisheit S; Sonnenschein K; Korte L; Haertlé M; Thum T; Bauersachs J; Sedding DG; Daniel JM
Cardiovasc Res; 2017 Nov; 113(13):1653-1663. PubMed ID: 29088375
[TBL] [Abstract][Full Text] [Related]
11. Adipolin/CTRP12 protects against pathological vascular remodelling through suppression of smooth muscle cell growth and macrophage inflammatory response.
Ogawa H; Ohashi K; Ito M; Shibata R; Kanemura N; Yuasa D; Kambara T; Matsuo K; Hayakawa S; Hiramatsu-Ito M; Otaka N; Kawanishi H; Yamaguchi S; Enomoto T; Abe T; Kaneko M; Takefuji M; Murohara T; Ouchi N
Cardiovasc Res; 2020 Jan; 116(1):237-249. PubMed ID: 30874788
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone Attenuates Injury-Induced Neointima Formation in Mouse Femoral Artery Partially through the Activation of AMP-Activated Protein Kinase.
Osman I; Fairaq A; Segar L
Pharmacology; 2017; 100(1-2):64-73. PubMed ID: 28482342
[TBL] [Abstract][Full Text] [Related]
13. Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation.
Daniel JM; Reichel CA; Schmidt-Woell T; Dutzmann J; Zuchtriegel G; Krombach F; Herold J; Bauersachs J; Sedding DG; Kanse SM
J Thromb Haemost; 2016 Oct; 14(10):2058-2067. PubMed ID: 27431088
[TBL] [Abstract][Full Text] [Related]
14. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
[TBL] [Abstract][Full Text] [Related]
15. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
[TBL] [Abstract][Full Text] [Related]
16. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
17. IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury.
Kohno T; Urao N; Ashino T; Sudhahar V; Inomata H; Yamaoka-Tojo M; McKinney RD; Fukai T; Ushio-Fukai M
Am J Physiol Cell Physiol; 2013 Sep; 305(6):C591-600. PubMed ID: 23657573
[TBL] [Abstract][Full Text] [Related]
18. Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury.
Ishimura S; Furuhashi M; Mita T; Fuseya T; Watanabe Y; Hoshina K; Kokubu N; Inoue K; Yoshida H; Miura T
Sci Rep; 2014 Nov; 4():6943. PubMed ID: 25373918
[TBL] [Abstract][Full Text] [Related]
19. Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice.
Zhu L; Hao Y; Guan H; Cui C; Tian S; Yang D; Wang X; Zhang S; Wang L; Jiang H
Mol Cell Biochem; 2013 Jan; 373(1-2):53-62. PubMed ID: 23065380
[TBL] [Abstract][Full Text] [Related]
20. 10-Gingerol, a natural AMPK agonist, suppresses neointimal hyperplasia and inhibits vascular smooth muscle cell proliferation.
Deng B; Jiang XL; Xu YC; Chen S; Cai M; Deng SH; Ding WJ; Xu HL; Zhang SW; Tan ZB; Chen RX; Liu B; Zhang JZ
Food Funct; 2022 Mar; 13(6):3234-3246. PubMed ID: 35213678
[No Abstract] [Full Text] [Related]
[Next] [New Search]
